CANF insider transaction filings

Can-Fite BioPharma Ltd. — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-08. Screen CANF transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for CANF between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.

Recent Form 4 filings — Can-Fite BioPharma Ltd.

FiledFormInsiderReported transactionsSource
2026-06-084Farbstein Motti — CEO, CFO and COOGrant/award (A): 24,000 (derivative) @ $0EDGAR
2026-06-084Fishman Pnina — Chief Scientific Officer, DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CANF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →